Imperial College London

🇧🇪Belgium

Country: 🇧🇪Belgium

Ownership: Private

Established: 1907-07-08

Employees: 5K

Market Cap: -

Website: http://www.imperial.ac.uk

Clinical Trials

Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration

Not Applicable

Terminated

Conditions: Allograft
Venous Ulcer

Interventions: Other: dCELL® Human Dermis (decellularised dermal skin allograft - DCD)
Other: Compression bandaging therapy

First Posted Date: 2019-07-16

Last Posted Date: 2023-09-28

Lead Sponsor: Imperial College London

Target Recruit Count: 71

Registration Number: NCT04021316

Locations: 🇬🇧
North Bristol NHS Trust, Bristol, United Kingdom
🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom
🇬🇧
Aneurin Bevan University Health Board, Newport, United Kingdom

and more 14 locations

Carbohydrate Intake and Gut Hormone Release During Exercise

Not Applicable

Completed

Conditions: Obesity

Interventions: Dietary Supplement: Maltodextrin (carbohydrate)
Other: Rest
Other: Exercise
Other: Water

First Posted Date: 2019-07-15

Last Posted Date: 2024-08-09

Lead Sponsor: Imperial College London

Target Recruit Count: 12

Registration Number: NCT04019418

Locations: 🇬🇧
Imperial Clinical Research Facility, London, United Kingdom

Enhanced, Personalized and Integrated Care for Infection Management at the Point-Of-Care

Completed

Conditions: Antibiotic Resistant Infection
Infection

Interventions: Device: EPIC IMPOC

First Posted Date: 2019-07-10

Last Posted Date: 2021-08-31

Lead Sponsor: Imperial College London

Target Recruit Count: 33

Registration Number: NCT04013737

Locations: 🇬🇧
Imperial College London, London, United Kingdom

Haemodialysis fMRI Salt Appetite Study

Recruiting

Conditions: Excess Interdialytic Weight Gain
Dialysis

Interventions: Procedure: haemodialysis

First Posted Date: 2019-07-08

Last Posted Date: 2023-04-14

Lead Sponsor: Imperial College London

Target Recruit Count: 90

Registration Number: NCT04011254

Locations: 🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom

Activity, Balance and COPD (ABCOPD)

Recruiting

Conditions: COPD

Interventions: Other: No intervention being delivered.

First Posted Date: 2019-07-02

Last Posted Date: 2023-12-08

Lead Sponsor: Imperial College London

Target Recruit Count: 82

Registration Number: NCT04006015

Locations: 🇬🇧
National Heart and Lung Institute, Imperial College London, London, United Kingdom

Optimising Consultation Summaries to Promote Good Health

Completed

Conditions: Type1 Diabetes

Interventions: Other: Interview-Questionnaire

First Posted Date: 2019-06-28

Last Posted Date: 2024-04-22

Lead Sponsor: Imperial College London

Target Recruit Count: 9

Registration Number: NCT04002557

Locations: 🇬🇧
University College London Hospital, London, United Kingdom

Non-invasive Testing for Early oEesophageal Cancer and Dysplasia

Recruiting

Conditions: Barrett Esophagus
Oesophageal Cancer
Barretts Esophagus With Dysplasia

Interventions: Diagnostic Test: Breath test

First Posted Date: 2019-06-28

Last Posted Date: 2023-07-25

Lead Sponsor: Imperial College London

Target Recruit Count: 1000

Registration Number: NCT04001478

Locations: 🇬🇧
University Hospital Coventry and Warwickshire, Coventry, United Kingdom
🇬🇧
Newcastle Hospital NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom
🇬🇧
Imperial College Healthcare Trust, London, United Kingdom

and more 9 locations

PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation

Phase 3

Completed

Conditions: Atrial Fibrillation
Intracerebral Hemorrhage

Interventions: Drug: Apixaban Oral Tablet
Drug: Dabigatran
Drug: Edoxaban Tablets
Drug: Rivaroxaban

First Posted Date: 2019-06-25

Last Posted Date: 2024-06-11

Lead Sponsor: Imperial College London

Target Recruit Count: 319

Registration Number: NCT03996772

Locations: 🇩🇪
University Hospital Cologne, Cologne, Germany
🇩🇪
University Hospital Schleswig-Holstein Campus Luebeck, Luebeck, Germany
🇩🇪
Klinikum Altenburger Land, Altenburg, Germany

and more 22 locations

Transplant Antibody-Mediated Rejection: Guiding Effective Treatments

Phase 3

Active, not recruiting

Conditions: Antibody-mediated Rejection
Kidney Transplant Rejection

Interventions: Drug: Rituximab
Drug: Methylprednisolone
Procedure: Plasma Exchange
Drug: Intravenous Immunoglobulin

First Posted Date: 2019-06-21

Last Posted Date: 2021-04-01

Lead Sponsor: Imperial College London

Target Recruit Count: 3

Registration Number: NCT03994783

Locations: 🇬🇧
Imperial College London, London, United Kingdom

Cancer Loyalty Card Study

Completed

Conditions: Ovarian Neoplasms

Interventions: Other: Risk Factor Questionnaire
Other: Clinical Questionnaire

First Posted Date: 2019-06-21

Last Posted Date: 2022-07-29

Lead Sponsor: Imperial College London

Target Recruit Count: 624

Registration Number: NCT03994653

Locations: 🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy